Selective estrogen receptor degraders and uses thereof
US10647724B2 · kind B2 · utility
3Cited by
1References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2017 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Feb 3, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/048
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds of Formula (I) and Formula (II). The compounds described herein may be useful in treating proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.